Study looks at using the immune system to reduce prostate cancer risk
Wednesday, September 23, 2009 - 11:07
in Health & Medicine
ANN ARBOR, Mich. -- Immune therapies have been explored as a way to treat cancer after it develops. But a new study from the University of Michigan Comprehensive Cancer Center suggests that genetic risk of prostate cancer can be reduced by rescuing critical immune system cells.